Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The renin-angiotensin-aldosterone-system (RAAS) has gained increasing attention in the investigation of the pathogenesis of depression. Primary hyperaldosteronism (PA) is associated with a marked aldosterone excess. Prior studies on PA describe an increased prevalence of anxiety and sub-threshold depressive symptoms in these patients. METHODS: In a cross-sectional exploratory study we investigated 132 patients with PA. Twenty-seven patients were studied before initiation of specific treatment (U = untreated), 56 were studied 5.4 years after initiation of mineralocorticoid antagonist treatment (MRA) and 49 patients were studied 4.3 years after unilateral adrenalectomy (ADX). GAD-7 and PHQD self-rating questionnaires were used to assess symptoms for anxiety and depression. RESULTS: No significant difference was found between the three investigated groups. A higher prevalence for depression and anxiety compared to the normal population was found. Women of all groups had higher mean values compared to men, for depression in untreated patients this difference was found to be significant. Correlations between the psychopathology and hormones were only found for renin. Plasma renin concentration correlated significantly with anxious symptoms of untreated females. CONCLUSIONS: This study supports the RAAS to be involved in the pathogenesis of depression as patients with PA seem to be more depressive and anxious compared to the normal population. Gender differences in the regulation of the RAAS seem to be apparent, as females were more affected by the dysregulation than males.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 1×
“One plausible explanation might be the vascular theory of late-life depression which implicates cardiovascular risk factors in the aetiology of depression (Alexopoulos et al. 1997).”
BackgroundFunder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Gilbody, S., Richards, D., Brealey, S., & Hewitt, C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0333-y · Cited by 1,290 · cited 1×
“It has been described to discriminate well between mild, moderate and severe depressive symptoms (Gilbody et al. 2007).”
BackgroundGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“The GR function seems to be decreased (Pariante and Miller 2001), whereas the role of the MR is still not completely understood.”
BackgroundGender differences in depression
Parker, G., & Brotchie, H. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.492391 · Cited by 756
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
The coming out of the brain mineralocorticoid receptor
Joëls, M., Karst, H., DeRijk, R., & de Kloet, E. R. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.10.005 · Cited by 481 · cited 1×
“(Holsboer 1999, 2000, 2001) Several studies report the glucocorticoidreceptor (GR) and the mineralocorticoidreceptor (MR) to be disturbed in their function (de Kloet et al. 2005, 2008; Joels et al. 2008).”
BackgroundCorticosteroid hormones in the central stress response: Quick-and-slow
de Kloet, E. R., Karst, H., & Joëls, M. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.002 · Cited by 391
Ruiz, M. A., Zamorano, E., García-Campayo, J., Pardo, A., Freire, O., & Rejas, J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.010 · Cited by 298
Mineralocorticoid Receptor Function in Major Depression
Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.24 · Cited by 204 · cited 1×
“Some studies suggest an increase in MR function as found by Young et al. (2003) and an upregulation of MR-gene expression in the hypothalamus of depressed patients (Wang et al. 2008).”
Background
Research works printed but not linked: 57
- Anstey KJ, 2009, Psychosom Med, 71, 937, 10.1097/PSY.0b013e3181beab60 · DOI
- Avery TL, 1984, N Z Med J, 97, 537
- Baghai TC, 2006, Mol Psychiatry, 11, 1003, 10.1038/sj.mp.4001884 · DOI
- Barden N, 1995, Trends Neurosci, 18, 6, 10.1016/0166-2236(95)93942-Q · DOI · Paper page
- 10.1016/j.psyneuen.2008.08.018 · DOI
- Bitran D, 1998, Pharmacol Biochem Behav, 60, 879, 10.1016/S0091-3057(98)00071-9 · DOI
- 10.1080/00221325.1988.10532148 · DOI
- Blanchard-Fields F, 1988, Psychol Aging, 3, 197, 10.1037/0882-7974.3.2.197 · doi:10.1037/0882-7974.3.2.197
- Born-Frontsberg E, 2009, J Clin Endocrinol Metab, 94, 1125, 10.1210/jc.2008-2116 · DOI · Paper page
- Briones-Aranda A, 2009, Pharmacol Biochem Behav, 92, 182, 10.1016/j.pbb.2008.11.008 · DOI
- 10.2165/00023210-200923070-00004 · DOI
- Chalmers DT, 1993, J Neurosci, 13, 914, 10.1523/JNEUROSCI.13-03-00914.1993 · DOI · Paper page
- Chen PS, 2006, Int Psychogeriatr, 18, 445, 10.1017/S1041610205002796 · DOI · Paper page
- 10.1310/tsr1501-13 · DOI · Paper page
- Daig I, 2009, Qual Life Res, 18, 669, 10.1007/s11136-009-9481-3 · DOI
- de Kloet ER, 2005, Nat Rev Neurosci, 6, 463, 10.1038/nrn1683 · DOI · Paper page
- de Kloet ER, 2008, Front Neuro endocrinol, 29, 268
- 10.1207/s15327752jpa4905_10 · DOI · Paper page
- Emanuele E, 2005, Arch Med Res, 36, 544, 10.1016/j.arcmed.2005.03.046 · DOI
- Fischer E, 2011, Rev Endocr Metab Disord, 12, 43, 10.1007/s11154-011-9163-7 · DOI
- Golden SH, 2007, Psychosom Med, 69, 529, 10.1097/PSY.0b013e3180f61c5c · DOI · Paper page
- 10.1080/00221320209598689 · DOI
- Hlavacova N, 2008, Horm Behav, 54, 90, 10.1016/j.yhbeh.2008.02.004 · DOI
- 10.1016/0306-4522(94)00407-V · DOI
- Holsboer F, 2000, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 · DOI · Paper page
- 10.1016/S0165-0327(00)00352-9 · DOI · Paper page
- Kellner M, 2008, Eur J Pharmacol, 583, 372, 10.1016/j.ejphar.2007.07.072 · DOI
- Khurshid KA, 2005, Am J Psychiatry, 162, 1226, 10.1176/appi.ajp.162.6.1226 · DOI
- Komukai K, 2010, Fundam Clin Pharmacol, 24, 687, 10.1111/j.1472-8206.2010.00854.x · DOI · Paper page
- Korte SM, 1995, Psychoneuroendocrinology, 20, 385, 10.1016/0306-4530(94)00069-7 · DOI · Paper page
- Kuroda Y, 1994, Brain Res, 648, 157, 10.1016/0006-8993(94)91916-X · DOI
- Lippi G, 2009, Semin Thromb Hemost, 35, 325, 10.1055/s-0029-1222611 · DOI · Paper page
- Lopez JF, 1998, Biol Psychiatry, 43, 547, 10.1016/S0006-3223(97)00484-8 · DOI · Paper page
- Lopez JF, 1999, Biol Psychiatry, 45, 934, 10.1016/S0006-3223(98)00224-8 · DOI
- Malinow KC, 1979, J Clin Psychiatry, 40, 358
- Meijer OC, 1994, Eur J Pharmacol, 266, 255, 10.1016/0922-4106(94)90134-1 · DOI · Paper page
- 10.1161/01.HYP.0000079505.25750.11 · DOI · Paper page
- Murck H, 2003, BMC Psychiatry, 3, 15, 10.1186/1471-244X-3-15 · DOI · Paper page
- Murck H, 2006, Pharmacopsychiatry, 39, 23, 10.1055/s-2006-931476 · DOI
- Panagiotakos DB, 2008, J Clin Nurs, 17, 688, 10.1111/j.1365-2702.2007.02056.x · DOI
- Reincke M, 2009, J Clin Endocrinol Metab, 94, 869, 10.1210/jc.2008-1851 · DOI · Paper page
- Reincke M, 2010, Horm Metab Res, 42, 435, 10.1055/s-0029-1246189 · DOI · Paper page
- Reul JM, 1993, Endocrinology, 133, 312, 10.1210/endo.133.1.8391426 · doi:10.1210/endo.133.1.8391426 · Paper page
- Rief W, 2004, J Affect Disord, 82, 271, 10.1016/j.jad.2003.11.006 · DOI · Paper page
- Ruiz MA, 2010, J Affect Disord.
- Schirpenbach C, 2009, Dtsch Arztebl Int, 106, 305
- Schussler P, 2010, Neuropsychobiology, 61, 113, 10.1159/000279301 · DOI
- Seckl JR, 1992, Neuroendocrinology, 55, 621, 10.1159/000126180 · DOI · Paper page
- Smythe JW, 1997, Pharmacol Biochem Behav, 56, 507, 10.1016/S0091-3057(96)00244-4 · DOI
- Sonino N, 2006, Psychother Psychosom, 75, 327, 10.1159/000093956 · DOI · Paper page
- Sonino N, 2011, J Clin Endocrinol Metab., 96, 383, 10.1210/jc.2010-2723 · DOI · Paper page
- Vonend O, 2010, Wien Klin Wochenschr, 122, 65, 10.1007/s00508-010-1313-5 · DOI
- Wang SS, 2008, Mol Psychiatry, 13, 786, 10.1038/mp.2008.38 · DOI · Paper page
- Watkins LL, 2006, Psychosom Med, 68, 651, 10.1097/01.psy.0000228342.53606.b3 · DOI · Paper page
- Yau JL, 1995, Neuroscience, 66, 571, 10.1016/0306-4522(94)00612-9 · DOI · Paper page
- Yau JL, 2002, Brain Res Mol Brain Res, 106, 117, 10.1016/S0169-328X(02)00418-7 · DOI
- Zhong P, 1995, Brain Res Mol Brain Res, 29, 23, 10.1016/0169-328X(94)00225-4 · DOI · Paper page
Cited by
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Self-citationSteroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Self-citationThe multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Metadata
- Authors
- Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., Beuschlein, F., & Reincke, M.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2012-05-08
- Volume
- 15
- Issue
- 1
- Pages
- 26-35
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2140262600
- Cited by
- 73
- References
- 14
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study. https://app.cochat.ai/papers/10.3109/15622975.2012.665480
- The paper
- Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., Beuschlein, F., & Reincke, M. (2014). Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622975.2012.665480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.